Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "The Progressive Skeletal Muscle and Body Weight Loss in Cancer Patients"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (10 April 2023) | Viewed by 2922
Special Issue Editors
Interests: anxiety; cachexia; cancer care facilities; depression; dyspnea; humanities; nausea; pain; palliative care; psychiatry
Interests: Antibody therapy; chemotherapy/systemic therapy; early breast cancer; hormone therapy; metastases
Special Issue Information
Cancer cachexia is defined as a syndrome characterised by anorexia, systemic inflammation, ongoing loss of muscle mass (with or without loss of fat mass), and weight loss, followed by a poor functional state and a limited ability to receive antineoplastic therapy. It is defined as weight loss greater than 5%, or weight loss greater than 2% in individuals showing a body-mass index (BMI) <20 kg/m2 or loss of skeletal muscle mass (sarcopenia).
Cancer cachexia is estimated to affect up 50–80% of cancer patients, accounting up to 20% of cancer deaths. Negative protein and energy balance go hand in hand with reduced food intake and abnormal metabolism, leading to a complex pathophysiological process. Cachexia is classified in various stages, precachexia to cachexia to refractory cachexia. Still, there is no standard of care to manage cancer cachexia. Improvement in physical function seems crucial, as cancer cachexia cannot be fully reversed by conventional nutritional support.
This Special Issue should provide information upon assessment, catabolic drive, practice guidelines, clinical management, as well as pharmacologic and non-pharmacologic management of cancer cachexia.
Prof. Dr. Eva Katharina Masel
Prof. Dr. Christoph Wiltschke
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Diet Therapy
- Medical Oncology
- Nutritional Status
- Nutrition Therapy
- Palliative Care
- Physical Therapy Modalities